ABSTRACT Fifty five patients underwent thymic surgery at Papworth Hospital from April 1964 to March 1984. The number presenting and the percentage with symptoms annually remained unchanged during this period. Forty four of these 55 patients had tumours. Twenty eight had thymomas (18% of whom had myasthenia gravis and 7% red cell aplasia), nine Hodgkin's disease, four germ cell tumours, and three secondary carcinomatous tumours. Five tumours were cystic. Six further patients had non-tumourous cystic lesions (four simple, one foregut, one lymphangiectatic). The remaining five patients had follicular hyperplasia; all of these had myasthenia gravis. Complete excision was performed in 41 of the 55 patients. So far survival is 100% in those with benign lesions other than benign thymomas, where the survival was 70% at five years. Those with malignant thymomas had a 60% survival rate at five years and those with Hodgkin's disease 29%.
The thymus, predominantly a third pharyngeal pouch derivative, rarely requires surgery. Since Weigart' showed an association between myasthenia gravis and thymoma in 1901, many clinical syndromes have been linked with thymic pathology and attention has been focused on these associations, so that there have been few studies of the whole spectrum of thymic disease.25 For this reason we undertook a retrospective study of all patients with thymic disease managed surgically over 20 years.
Methods
All patients having thymic surgery from 1 April 1964 to 31 March 1984 were included in this study. The pathology was assessed by one of us (PGIS) throughout this period. The case notes of the patients were used to obtain the details of the mode of presentation, diagnosis, surgical treatment, and histology of the excised thymus. The long term outcome was assessed by the patient's survival, evidence of recurrence of symptoms, thymic disease, and development of possible associated syndromes. These data were collected from the hospital notes, the records of other departments into whose care the patients had been transferred, and a questionnaire sent to the patient's general practitioner. Patients were classified according to their pathology, on the Address for reprint requests: Dr Stephen R Large, Cardiothoracic Surgical Unit, St Bartholomew's Hospital, London ECI. Accepted 29 July 1985 basis of the classification proposed by Rosai Metastases had previously been reported as rare. 5 Rosai and Levin2 found that only 7% of their patients with thymoma had malignant change, but in other reviews10 11 there is an incidence similar to ours. It is unlikely that thymic malignancy is becoming more common; the small numbers of cases in these reviews2 1o 11 are probably responsible for the variation.
All the patients with cystic lesions and germ cell tumours have survived. Five year actuarial survival rates of 70% and 60% for benign and malignant thymomas respectively is similar to those of recent reports.9 10 A 29% actuarial survival of patients with Hodgkin's disease was unexpectedly low, as it has been shown that thymic tumours are common in patients with Hodgkin's disease and do not affect prognosis. ' http://group.bmj.com/subscribe/ To subscribe to BMJ go to: bronchial challenge testing in our study of the prevalence of asthma. In commenting on our finding that over one quarter of children had a history of current or past wheeze, they state that "clearly, not all of these children had asthma." What did they have? Many but not all of these children showed increased airway responsiveness, as did a proportion of those with a history of dry cough. If, as advocated by Woolcock and colleagues,2 asthma is diagnosed only when symptoms are accompanied by demonstrable airway hyperresponsiveness, much past asthma, and even mild current asthma, will not be diagnosed. Perhaps our problem is the use of the word "asthma." We can demonstrate and measure degrees of bronchial responsiveness, and we can obtain and clinically categorise a history of wheezing or cough. While symptoms and hyperresponsiveness are often found together, they are not synonymous, and neither is exactly equivalent to variable airflow obstruction, which is the hallmark of asthma. We should report both the history of symp This is a small, compact paperback which, although primarily about aerosols and delivery systems, covers many aspects of drug therapy in the treatment of diseases of airflow obstruction. The book is unusual in that it has no foreword by the author, and thus leaves the reviewer undecided on the audience the author intended to reach a problem exacerbated when he is reviewing North American publications for British readers and not entirely resolved after it has been read in its entirety. The history of inhalation therapy is reviewed, and followed by an excellent chapter on aerosols, their deposition and generation. This is followed by a discourse on the pharmacokinetics of inhaled substances, which does highlight the present paucity of data on bronchodilators. Patients' and doctors' errors in the use of hand held aerosols and means of overcoming such problems are well described. Metabolism, structure, and function followed by pharmacology make up the major portion of the book, but the inherent safety of selective 3 stimulants is also covered. Drug dose differences between the various delivery systems are highlighted. 
